Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Impact of a Gut-derived Metabolite on Anxiety Behavior of Human Subjects Based on Their Cognitive Orientation Variation

NCT05388630 is registered in ClinicalTrials.gov with Endominance as lead sponsor.

NCT NCT05388630
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05388630 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Impact of a Gut-derived Metabolite on Anxiety Behavior of Human Subjects Based on Their Cognitive Orientation Variation
Lead sponsor
Endominance
Phase
Observational
Overall status
Unknown status
Start date
June 1, 2022
Completion date
May 30, 2023
Enrollment
2,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anxiety, depression, microbiome, mood disorders, neurodegeneration